ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

RNXT RenovoRx Inc

1.46
0.00 (0.00%)
プレマーケット
最終更新日: 20:00:00
15分遅延
名称 銘柄コード 市場 種別
RenovoRx Inc RNXT NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.00 0.00% 1.46 20:00:00
始値 安値 高値 終値 前日終値
1.46
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/5/1422:00BWRenovoRx to Participate in Fireside Chat at the A.G.P...
2024/5/1313:15EDGAR2Form EFFECT - Notice of Effectiveness
2024/5/1106:21EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/5/1105:50EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
2024/5/1105:47EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
2024/5/0222:00BWRenovoRx CEO Shaun R. Bagai to Present at the Aegis Capital..
2024/4/1821:30BWRenovoRx Regains Compliance with Nasdaq Stockholders’ Equity..
2024/4/1621:30BWRenovoRx Highlights Recent Presentation of Clinical Data..
2024/4/1521:00BWRenovoRx Closes $11.1 Million Private Placement, Providing..
2024/4/0821:30BWRenovoRx Announces $11.1 Million at Market Private Placement
2024/4/0521:30BWRenovoRx to Present at the Canaccord Genuity Horizons in..
2024/3/1222:00BWRenovoRx to Present at the 36th Annual ROTH Conference on..
2024/3/0906:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0906:05BWRenovoRx Highlights Key Leadership Promotions
2024/2/1309:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1006:30EDGAR2Form 8-K - Current report
2024/2/0622:30BWRenovoRx CEO Issues Letter to Shareholders
2024/1/3109:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/3108:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/3108:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/3108:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/2923:06EDGAR2Form 8-K - Current report
2024/1/2922:30BWRenovoRx Closes $6.1 Million Private Placement
2024/1/2411:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/2411:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/2411:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0222:30EDGAR2Form 8-K - Current report
2023/12/2122:30BWRenovoRx Engages Oklahoma University (OU) Health as First..
2023/12/1922:30BWRenovoRx Announces Clinical Data Abstract at the 2024..
2023/12/1906:15EDGAR2Form 8-K - Current report
2023/12/1322:31BWRenovoRx Files New International Patent for Novel Targeted..
2023/11/2803:23EDGAR2Form DEF 14A - Other definitive proxy statements
2023/11/1807:30EDGAR2Form PRE 14A - Other preliminary proxy statements
2023/11/1622:35BWRenovoRx Expands Scientific Advisory Board with Appointment..
2023/11/1422:30BWRenovoRx Reports Third Quarter 2023 Financial Results and..
2023/11/1406:58EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/0706:15EDGAR2Form 8-K - Current report
2023/10/0505:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/10/0305:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/10/0305:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/10/0305:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/10/0221:30BWRenovoRx to Present at the ROTH MKM Healthcare Opportunities..
2023/8/2605:15EDGAR2Form 8-K - Current report
2023/8/1721:30EDGAR2Form 8-K - Current report
2023/8/1721:30BWRenovoRx Reports Second Quarter 2023 Financial Results and..
2023/8/1703:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/1604:57EDGAR2Form NT 10-Q - Notification of inability to timely file Form..
2023/7/3121:30BWRenovoRx to Present at the 43rd Annual Canaccord Genuity..
2023/7/2021:00BWRenovoRx and Imugene Announce Collaboration to Deliver..
2023/6/2922:27EDGAR2Form 8-K - Current report

最近閲覧した銘柄

Delayed Upgrade Clock